Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset - HMS LINCS Database

Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells	Antibodies

|<
<<
Previous
Page 1933 of 3330
Next
>>
>
48301 to 48325 of 83232 records
per page:

Cell	Clinical Subtype	Transcriptional Subtype	Small Molecule	Perturbagen Target	Perturbagen Class	Perturbagen Concentration	Perturbagen Conc Unit	Biological Replicate ID	Relative Cell Count	Normalized Growth Rate Inhibition Value	Nominal Division Rate
BT-20	TNBC	Basal A	MG-132	Proteasome	Proteasome	0.0213	uM	10581.145	0.9592	0.9099	0.9044
BT-20	TNBC	Basal A	MG-132	Proteasome	Proteasome	0.0213	uM	10581.145	0.9592	0.9099	0.9044
BT-20	TNBC	Basal A	MG-132	Proteasome	Proteasome	0.107	uM	10581.145	1.0006	1.0013	0.9044
BT-20	TNBC	Basal A	MG-132	Proteasome	Proteasome	0.107	uM	10581.145	1.0006	1.0013	0.9044
BT-20	TNBC	Basal A	MG-132	Proteasome	Proteasome	0.533	uM	10581.145	0.5202	-0.0291	0.9044
BT-20	TNBC	Basal A	MG-132	Proteasome	Proteasome	0.533	uM	10581.145	0.5202	-0.0291	0.9044
BT-20	TNBC	Basal A	MG-132	Proteasome	Proteasome	2.67	uM	10581.145	0.0621	-0.9074	0.9044
BT-20	TNBC	Basal A	MG-132	Proteasome	Proteasome	2.67	uM	10581.145	0.0621	-0.9074	0.9044
BT-20	TNBC	Basal A	MG-132	Proteasome	Proteasome	13.3	uM	10581.145	0.0520	-0.9238	0.9044
BT-20	TNBC	Basal A	MG-132	Proteasome	Proteasome	13.3	uM	10581.145	0.0520	-0.9238	0.9044
BT-20	TNBC	Basal A	MG-132	Proteasome	Proteasome	66.7	uM	10581.145	0.0648	-0.9030	0.9044
BT-20	TNBC	Basal A	MG-132	Proteasome	Proteasome	66.7	uM	10581.145	0.0648	-0.9030	0.9044
BT-20	TNBC	Basal A	MG-132	Proteasome	Proteasome	0.000171	uM	11854.145	0.9840	0.9724	1.1581
BT-20	TNBC	Basal A	MG-132	Proteasome	Proteasome	0.000171	uM	11854.145	0.9840	0.9724	1.1581
BT-20	TNBC	Basal A	MG-132	Proteasome	Proteasome	0.000853	uM	11854.145	0.9399	0.8957	1.1581
BT-20	TNBC	Basal A	MG-132	Proteasome	Proteasome	0.000853	uM	11854.145	0.9399	0.8957	1.1581
BT-20	TNBC	Basal A	MG-132	Proteasome	Proteasome	0.00427	uM	11854.145	0.9395	0.8951	1.1581
BT-20	TNBC	Basal A	MG-132	Proteasome	Proteasome	0.00427	uM	11854.145	0.9395	0.8951	1.1581
BT-20	TNBC	Basal A	MG-132	Proteasome	Proteasome	0.0213	uM	11854.145	0.9677	0.9441	1.1581
BT-20	TNBC	Basal A	MG-132	Proteasome	Proteasome	0.0213	uM	11854.145	0.9677	0.9441	1.1581
BT-20	TNBC	Basal A	MG-132	Proteasome	Proteasome	0.107	uM	11854.145	0.9308	0.8799	1.1581
BT-20	TNBC	Basal A	MG-132	Proteasome	Proteasome	0.107	uM	11854.145	0.9308	0.8799	1.1581
BT-20	TNBC	Basal A	MG-132	Proteasome	Proteasome	0.533	uM	11854.145	0.6113	0.3076	1.1581
BT-20	TNBC	Basal A	MG-132	Proteasome	Proteasome	0.533	uM	11854.145	0.6113	0.3076	1.1581
BT-20	TNBC	Basal A	MG-132	Proteasome	Proteasome	2.67	uM	11854.145	0.0665	-0.8074	1.1581

|<
<<
Previous
Page 1933 of 3330
Next
>>
>
48301 to 48325 of 83232 records
per page:

HMS LINCS Project

Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)